Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy
Status: | Recruiting |
---|---|
Conditions: | Blood Cancer, Blood Cancer, Hematology |
Therapuetic Areas: | Hematology, Oncology |
Healthy: | No |
Age Range: | 18 - 99 |
Updated: | 1/6/2019 |
Start Date: | January 2, 2018 |
End Date: | February 2025 |
Contact: | Timothy Krepski, RN |
Email: | tkrepsk1@fairview.org |
Phone: | 612-273-2800 |
This is a prospective, observational study to collect stool and blood from acute myeloid
leukemia patients undergoing intensive chemotherapy.
leukemia patients undergoing intensive chemotherapy.
Inclusion Criteria:
- Adults (ages 18 - 99 years) undergoing inpatient intensive chemotherapy for newly
diagnosed, refractory, or relapsed AML. Patients may or may not have been exposed to
any type of therapy before.
- Any intensive chemotherapy regimen defined as a planned ~4 week inpatient stay.
Chemotherapy may be delivered for any number of days and on any schedule. Patients may
be discharged from the hospital sooner than 4 weeks if the treating physician choose
so, but the expectation at the initiation of chemotherapy must be ~4 weeks of
inpatient stay, as is typical.
- Able to provide written voluntary consent before performance of any study related
procedure.
We found this trial at
1
site
425 E River Pkwy # 754
Minneapolis, Minnesota 55455
Minneapolis, Minnesota 55455
612-624-2620
Phone: 612-963-0539
Masonic Cancer Center at University of Minnesota The Masonic Cancer Center was founded in 1991....
Click here to add this to my saved trials